On 5 November 2016
SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 2016, to consider and approve the Standalone Unaudited Financial Results for the quarter ended on 30 September 2016 along-with Limited Review Report thereon.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
